The P2 receptors and congenital platelet function defects

Seminars in Thrombosis and Hemostasis

Volumn 31, Issue 2, 2005, Pages 168-173

  Cattaneo, Marco ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Congenital defects; Dysfunctional platelets; P2 receptors; P2Y 12 defects; Platelets

Indexed keywords

ADENINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ARGININE; CYCLIC AMP; CYTOSINE; DESMOPRESSIN; GLUTAMINE; MUTANT PROTEIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C BETA; PURINE P2 RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y12 RECEPTOR; THYMINE; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; CALCIUM MOBILIZATION; CASE REPORT; CHO CELL; CONGENITAL BLOOD CLOTTING DISORDER; FEMALE; FRAMESHIFT MUTATION; GENE LOCATION; GENE LOCUS; GENETIC TRANSFECTION; HOMOZYGOSITY; HUMAN; MALE; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; THROMBOCYTE SHAPE;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; BLOOD PLATELET DISORDERS; CHO CELLS; CODON, NONSENSE; CRICETINAE; CYCLIC AMP; FRAMESHIFT MUTATION; GENE SILENCING; GENOTYPE; HUMANS; MEMBRANE PROTEINS; MUTATION, MISSENSE; PLATELET AGGREGATION; RATS; RECEPTORS, PURINERGIC P2; TRANSFECTION;

EID: 18044373075     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-869522     Document Type: Review

References (47)

1. Cattaneo M, Gachet C, Cazenave JP, Packham MA. Adenosine diphosphate (ADP) does not induce thromboxane A2 generation in human platelets. Blood 2002;99:3868-3869
2. Cattaneo M, Cachet C. ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 1999;19:2281-2285
3. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci U S A 1998;95:8070-8074
4. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998;50:413-492
5. North RA. Families of ion channels with two hydrophobic segments. Curr Opin Cell Biol 1996;8:474-483
6. Brake AJ, Wagenbach MJ, Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 1994;371:519-523
7. Valera S, Hussy N, Evans RJ, et al. A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 1994;371:516-519
8. Leon C, Hechler B, Vial C, et al. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 1997;403:26-30
9. Hollopeter G, Jantzen HM, Vincent D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001;409:202-207
10. Zhang FL, Luo L, Gustafson E, et al. ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 2001;276:8608-8615
11. Sun B, Li J, Okahara K, Kambayashi J. P2X1 purinoceptor in human platelets. Molecular cloning and functional characterization after heterologous expression. J Biol Chem 1998;273: 11544-11547
12. Clifford EE, Parker K, Humphreys BD, Kertesy SB, Dubyak GR. The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes. Blood 1998;91:3172-3181
13. Vial C, Hechler B, Leon C, Cazenave JP, Cachet C. Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb Haemost 1997;78:1500-1504
14. Scase TJ, Heath MF, Allen JM, Sage SO, Evans RJ. Identification of a P2X1 purinoceptor expressed on human platelets. Biochem Biophys Res Commun 1998;242:525-528
15. Mahaut-Smith MP, Ennion SJ, Rolf MG, Evans RJ. ADP is not an agonist at P2X(1) receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. Br J Pharmacol 2000;131:108-114
16. Hechler B, Leon C, Vial C, et al. The P2Y1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation. Blood 1998;92:152-159
17. Savi P, Beauverger P, Labouret C, et al. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett 1998;422:291-295
18. Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998;273:2030-2034
19. Jarvis GE, Humphries RG, Robertson MJ, Leff P. ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors. Br J Pharmacol 2000;129:275-282
20. Geiger J, Honig-Liedl P, Schanzenbacher P, Walter U. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. Eur J Pharmacol 1998;351: 235-246
21. Fagura MS, Dainty IA, McKay GD, et al. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors. Br J Pharmacol 1998;124:157-164
22. Daniel JL, Dangelmaier C, Jin J, et al. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 1998;273:2024-2029
23. Jantzen HM, Gousset L, Bhaskar V, et al. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Thromb Haemost 1999;81:111-117
24. Leon C, Hechler B, Freund M, et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 1999; 104:1731-1737
25. Fabre JE, Nguyen M, Latour A, et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999; 5:1199-1202
26. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992;80:2787-2796
27. Leon C, Vial C, Gachet C, et al. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation. Thromb Haemost 1999;81:775-781
28. Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti ML. Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol 2000;20:E101-E106
29. Cattaneo M, Lombardi R, Zighetti ML, et al. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Thromb Haemost 1997;77: 986-990
30. Trumel C, Payrastre B, Plantavid M, et al. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 1999;94: 4156-4165
31. Cattaneo M, Canciani MT, Lecchi A, et al. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood 1990;75:1081-1086
32. Savi P, Herbert JM. Pharmacology of ticlopidine and clopidogrel. Haematologica 2000;85:73-77
33. Humphries RG. Pharmacology of AR-C69931MX and related compounds: from pharmacological tools to clinical trials. Haematologica 2000;85:66-72
34. Rolf MG, Mahaut-Smith MP. Effects of enhanced P2X1 receptor Ca2+ influx on functional responses in human platelets. Thromb Haemost 2002;88:495-502
35. Oury C, Toth-Zsamboki E, Thys C, et al. The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost 2001;86:1264-1271
36. Cattaneo M, Marchese P, Jacobson KA, Ruggeri ZM. The P2X1 receptor for ATP plays an essential role in platelet aggregation at high shear. Haematology J. 2003;4(suppl 2): 150 (abst)
37. Hechler B, Lenain N, Marchese P, et al. A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med 2003;198:661-667
38. Gachet C, Cattaneo M, Ohlmann P, et al. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol 1995;91:434-444
39. Conley PB, Jurek MM, Vincent D, Lecchi A, Cattaneo M. Unique mutations in the P2Y12 locus of patients with previously described defects in ADP-dependent aggregation. Blood 2001;98:43b (abst)
40. Nurden P, Savi P, Heilmann E, et al. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J Clin Invest 1995;95:1612-1622
41. Cattaneo M, Zighetti ML, Lombardi R, et al. Phenotypic and genotypic characterization of a congenital bleeding disorder caused by a dysfunctional P2Y12 ADP receptor. Blood 2001; 98:443a (abst)
42. Moro S, Hoffmann C, Jacobson KA. Role of the extracellular loops of G protein-coupled receptors in ligand recognition: a molecular modeling study of the human P2Y1 receptor. Biochemistry 1999;38:3498-3507
43. Moro S, Guo D, Camaioni E, et al. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J Med Chem 1998;41:1456-1466
44. Cattaneo M, Lecchi A. Patients with congenital abnormality of platelet aggregation induced by Ca(2+) ionophores may have a defect of the platelet P2Y(12) receptor for ADP. Br J Haematol 2001;115:485-487
45. Cattaneo M, Zighetti ML, Lombardi R, Mannucci PM. Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP. Br J Haematol 1994;88:826-829
46. Oury C, Lenaerts T, Peerlinck K, Vermylen J, Hoylaerts MF. Congenital deficiency of the phospholipase mC coupled platelet P2Y1 receptor leads to a mild bleeding disorder. Thromb Haemost 1999;85(suppl):20 (abst)
47. Oury C, Toth-Zsamboki E, Van Geet C, et al. A natural dominant negative P2X1 receptor due to deletion of a single amino acid residue. J Biol Chem 2000;275:22611-22614